Kwality Pharmaceuticals Ltd (KWAL)

Currency in INR
3,357.10
-270.15(-7.45%)
Closed·
Advertisement
Unusual trading volume
KWAL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,328.503,634.90
52 wk Range
828.803,725.45
Key Statistics
Bid/Ask
3,343.00 / 3,357.10
Prev. Close
3,627.25
Open
3,634.9
Day's Range
3,328.5-3,634.9
52 wk Range
828.8-3,725.45
Volume
20.38K
Average Volume (3m)
8.43K
1-Year Change
231.4836%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KWAL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Kwality Pharmaceuticals Ltd Earnings Call Summary for Q1/2027

  • Kwality raised FY2027 revenue guidance to INR 700+ crore from INR 600 crore, targeting EBITDA margins of 26%-27% and INR 1,500 crore by FY2030.
  • Shares surged 20% to record high of INR 3,130.85 following upgraded outlook driven by biosimilars, hormones, and complex injectables expansion.
  • Q1 FY2027 revenue reached INR 160 crore; gross margin compressed to 53% from 56%-57% due to shift toward lower-margin ROW markets.
  • Hormone plant launch scheduled November 2026, oncology expansion by March 2027, with KEYTRUDA biosimilar targeted for commercial launch before end of 2028.
  • Management expects debtor days to improve to 165-170 days by FY2027-end from 200 days; planned CapEx of INR 185-190 crore excluding biosimilar trials.
Last Updated: 10/08/2026, 12:52
Read Full Transcript

Earnings

Latest Release
10/08/2026
EPS / Forecast
24.69 / --
Revenue / Forecast
1.62B / --
EPS Revisions
Last 90 days

Compare KWAL to Peers and Sector

Metrics to compare
KWAL
Peers
Sector
Relationship
P/E Ratio
43.0x32.1x−0.3x
PEG Ratio
0.500.460.00
Price/Book
10.5x4.7x2.6x
Price / LTM Sales
6.3x3.8x3.1x
Upside (Analyst Target)
-7.1%47.6%
Fair Value Upside
Unlock3.8%5.6%Unlock

Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including capsules, eye and ear drops, ointments and creams, pouches and sachets, sanitizers, tablets, suppositories, injectable vials and ampoules, liquid orals, lyophilized products, syrups, and various other categories, such as general, beta-lactam, cephalosporins, oncology, biologics, and hormones and specialty injectables. It also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations. Kwality Pharmaceuticals Limited was incorporated in 1983 and is based in Amritsar, India.

Employees
1137
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
181.000.00%607.64K
Other Institutional Investors
538.33K5.19%1.81B
Public Companies & Retail Investors
9.84M94.81%33.03B
Total
10.38M100.00%34.83B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ark Global Emerging Companies, LP2.11%218,896734,856
Seven Canyons Advisors, LLC2.11%218,896734,856

People Also Watch

505.35
JEEN
-0.17%
1,581.85
NITA
+0.01%
601.50
TIMX
+1.91%
1,846.90
ATLE
+9.37%
3,321.90
SEPL
-0.81%

FAQ

What Is the Kwality Pharma (BSE: KWAL) Share Price Today?

The Kwality Pharma stock price today is 3,357.10 INR.

What Stock Exchange Does Kwality Pharma (KWAL) Trade On?

Kwality Pharma is listed and trades on the Bombay Stock Exchange.

What Is the Ticker (Stock Symbol) for Kwality Pharma?

The stock symbol (also called a 'ticker') for Kwality Pharma is "KWAL."

What Is the Current Kwality Pharma Market Capitalisation?

As of today, Kwality Pharma (BSE: KWAL) market cap is 34.83B INR.

What Is Kwality Pharma's (KWAL) Earnings Per Share (TTM)?

The Kwality Pharma EPS is currently 78.10 (Trailing Twelve Months).

Is KWAL a Buy or Sell From a Technical Analyst Perspective?

Based on today's Kwality Pharma moving averages and other technical indicators, the daily buy/sell signal for KWAL stock is Strong Buy.

How Many Times Has Kwality Pharma Stock Split?

Kwality Pharma has split 1 times. (See the KWAL stock split history page for full effective split date and price information.)

How Many Employees Does Kwality Pharma Have?

Kwality Pharma has 1137 employees, based on their latest Companies House report.

What is the current trading status of Kwality Pharma (BSE: KWAL)?

As of 22/08/2026, Kwality Pharma (KWAL) is trading at a share price of 3,357.10 INR, with a previous close of 3,627.25 INR. The stock has fluctuated within a day range of 3,328.50 INR to 3,634.90 INR, while its 52-week range spans from 828.80 INR to 3,725.45 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.